United States· US:84954-0001_4e3862ba-de25-ecf7-e063-6294a90aa7fc
Hongdongsam najel-na
A medicinal product containing apple cider vinegar, registered in United States by Hyosungwon.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- APPLE CIDER VINEGAR
- Manufacturer
- Hyosungwon
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1184954-0001-1
- ndc118495400011750 mL in 1 PACKAGE (84954-0001-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Apple cider vinegar in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4cd8e6a-417c-4b37-aa14-837599a07b8e GET /v1/drugs/f4cd8e6a-417c-4b37-aa14-837599a07b8e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "92.7",
"substance": "APPLE CIDER VINEGAR",
"productndc": "84954-0001",
"dosage_form": "SOAP",
"dea_schedule": null,
"strength_unit": "g/100mL",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about apple cider vinegar.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.